Elranatamab

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 13:33:43 GMT 2023` Edited by `admin` on `Sat Dec 16 13:33:43 GMT 2023`
Protein Type	BISPECIFIC ANTIBODY
Protein Sub Type	IGG2
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	L0HR9A577V
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

Elranatamab

Official Name

English

elranatamab [INN]

Common Name

English

ANTI-CD3/ANTI-BCMA BISPECIFIC MONOCLONAL ANTIBODY PF-06863135

Common Name

English

RN613

Code

English

ELRANATAMAB [USAN]

Common Name

English

RN-613

Code

English

PF-06863135

Code

English

Elranatamab [WHO-DD]

Common Name

English

Immunoglobulin G2-kappa, anti-(Homo sapiens T-cell surface glycoprotein CD3 epsilon chain CD3E (T-cell surface antigen T3/Leu-4 epsilon chain)), human-Mus musculus monoclonal disulfide with immunoglobulin G2-kappa, anti-(Homo sapiens - Tumor necrosis fac

Common Name

English

Immunoglobulin G2 [224-arginine,265-alanine,330-serine,331-serine], anti-(human CD3 antigen ε-chain) (human-Mus musculus monoclonal PF-06863059 γ2-chain), disulfide with human-Mus musculus monoclonal PF-06863059 κ-chain, (223→217′)(227→221′)(2

Common Name

English

B-CELL MATURATION ANTIGEN (BCMA) CLUSTER OF DIFFERENTIATION 3 (CD3) BISPECIFIC MONOCLONAL ANTIBODY (MAB) ANTI-BCMA/ANTI-CD3 BISPECIFIC MAB

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

840721